Skip to Main Content

Author Details

Dianne M Finkelstein
Harvard Medical School
1985
199
73
PMIDPaper TitleJournal TitlePublished Year
34363462Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination.Clin Infect Dis2022
35818331Designing a longitudinal clinical trial based on a composite endpoint: Sample size, monitoring, and adaptation.Stat Med2022
30386969Estimation for an accelerated failure time model with intermediate states as auxiliary information.Lifetime Data Anal2020
31806543Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial.Lancet Oncol2020
29212345A pilot investigation of an iOS-based app for toilet training children with autism spectrum disorder.Autism2019
30206956Graphing the Win Ratio and its components over time.Stat Med2019
31256630Design and analysis of a clinical trial using previous trials as historical control.Clin Trials2019
30791872Are rare cancer survivors at elevated risk of subsequent new cancers?BMC Cancer2019
29242214Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.Cancer Discov2018
29872641Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis.Front Oncol2018
30854419Informatively clustering longitudinal microarrays using binary or survival outcome data.Commun Stat Case Stud Data Anal Appl2018
30315392Physical symptoms in long-term survivors of rare cancer.J Cancer Surviv2018
27894048Real world patterns of care in HER2-overexpressing breast cancer: Results of a survey of TEACH clinical trial investigators in 2011.Breast2017
35172508High-Content Biopsies Facilitate Molecular Analyses and Do Not Increase Complication Rates in Patients With Advanced Solid Tumors.JCO Precis Oncol2017
28143870Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.Clin Cancer Res2017
27761785Physical and psychological health in rare cancer survivors.J Cancer Surviv2017
26812695Global rank tests for multiple, possibly censored, outcomes.Biometrics2016
26856748Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project.Am J Gastroenterol2016
26829011Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy.Eur J Cancer2016
26908538Assessing survival benefit when treatment delays disease progression.Clin Trials2016
25582933A model-informed rank test for right-censored data with intermediate states.Stat Med2015
26562156Outcome-Driven Cluster Analysis with Application to Microarray Data.PLoS One2015
25888246Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.Breast Cancer Res2015
25847936TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.J Clin Oncol2015
25993282Evaluating Academic Scientists Collaborating in Team-Based Research: A Proposed Framework.Acad Med2015
25710962Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.J Natl Cancer Inst2015
25752740Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer.Eur J Cancer2015
25504083Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis.Breast Cancer Res Treat2015
24165578Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort study.Cancer Epidemiol Biomarkers Prev2014
26137536Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple Myeloma.EBioMedicine2014
25233398Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy.Br J Cancer2014
25199766Access to care issues adversely affect breast cancer patients in Mexico: oncologists' perspective.BMC Cancer2014
24781656Poor Survival for American Indians with Head and Neck Squamous Cell Carcinoma.Otolaryngol Head Neck Surg2014
24872111Breast cancer in China.Lancet Oncol2014
24696430Long-term risk of medical conditions associated with breast cancer treatment.Breast Cancer Res Treat2014
24687830Prospective validation of HLA-DRB1*07:01 allele carriage as a predictive risk factor for lapatinib-induced liver injury.J Clin Oncol2014
24501379A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network.Cancer Epidemiol Biomarkers Prev2014
24500790A joint test for progression and survival with interval-censored data from a cancer clinical trial.Stat Med2014
23234763Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.Lancet Oncol2013
23912961Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?Breast Cancer Res Treat2013
23628188Planning cancer control in Latin America and the Caribbean.Lancet Oncol2013
23812955Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker.J Natl Cancer Inst2013
23425984Strategies for developing biostatistics resources in an academic health center.Acad Med2013
22101228The Family Health Promotion Project (FHPP): design and baseline data from a randomized trial to increase colonoscopy screening in high risk families.Contemp Clin Trials2012
22846838Breast cancer in Mexico: a growing challenge to health and the health system.Lancet Oncol2012
22898638Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter?Pancreatology2012
22381937Breast cancer in Brazil: present status and future goals.Lancet Oncol2012
21394748A test for the relationship between a time-varying marker and both recovery and progression with missing data.Stat Med2011
22073940Web-browser encryption of personal health information.BMC Med Inform Decis Mak2011
21893500Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.Cancer Prev Res (Phila)2011
  • 1 - 50 of 199

Recommended Authors

University of Michigan School of Public Health ann arbor
Career Start Year 2009
Number of shared co-authors 7
Regeneron Pharmaceuticals
Career Start Year 2009
Number of shared co-authors 3
Center for Innovative Design and Analysis, University of Colorado, Aurora CO.
Career Start Year 2008
Number of shared co-authors 1
Duke University
Career Start Year 2005
Number of shared co-authors 3
University of California
Career Start Year 2003
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 0
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 2
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 2
University of California San Diego
Career Start Year 2000
Number of shared co-authors 3
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 1
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 2
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 6
Stanford University
Career Start Year 1997
Number of shared co-authors 6
The University of Kansas Medical Center
Career Start Year 1996
Number of shared co-authors 6
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 2
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 1994
Number of shared co-authors 1
Virginia Tech
Career Start Year 1994
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 5
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 7
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 2
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 5
St Jude Children's Research Hospital.
Career Start Year 1988
Number of shared co-authors 0
University of South Carolina
Career Start Year 1986
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1986
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 6
HIV Neurobehavioral Research Center (HNRC), university of california san diego
Career Start Year 1984
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 1
University of California san francisco
Career Start Year 1981
Number of shared co-authors 1
National Cancer Institute
Career Start Year 1975
Number of shared co-authors 1
Health Informatics Institute, University of South Florida
Career Start Year 1971
Number of shared co-authors 2

Collaborators

Mass General Hospital
Co-authored papers 30
Massachusetts General Hospital
Co-authored papers 15
Co-authored papers 10
Co-authored papers 7
University of Texas MD Anderson Cancer Center
Co-authored papers 7
Rollins School of Public Health, Emory University
Co-authored papers 6
New York University.
Co-authored papers 6
Co-authored papers 6
University of Michigan ann arbor
Co-authored papers 5
University of California irvine
Co-authored papers 5
UCL Great Ormond Street Institute of Child Health, University College London
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania
Co-authored papers 4
Dana-Farber Cancer Institute
Co-authored papers 3
College of Nursing, University of Iowa Hospitals and Clinics
Co-authored papers 3
Baylor College of Medicine
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Massachusetts General Hospital Cancer Center
Co-authored papers 2
Tufts University
Co-authored papers 2
University of California davis
Co-authored papers 2
Massachusetts General Hospital
Co-authored papers 2
Massachusetts General Hospital
Co-authored papers 2
University of North Carolina
Co-authored papers 2
Massachusetts General Hospital
Co-authored papers 2
Duke University
Co-authored papers 2
MD Anderson Cancer Center
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Division of Clinical Informatics, Beth Israel Deaconess Medical Center
Co-authored papers 2